Application 201849
- Type
- NDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | GLUCAGON | GLUCAGON HYDROCHLORIDE | POWDER;INTRAMUSCULAR, INTRAVENOUS | EQ 1MG BASE/VIAL | Yes | Yes |
| 002 | GLUCAGON | GLUCAGON HYDROCHLORIDE | POWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 1MG BASE/VIAL | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51662-1498 | GLUCAGON | GLUCAGON | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 63323-582 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-582 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-593 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-593 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-593 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-593 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-594 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-594 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-594 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-594 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-594 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-596 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 83367 | SUPPL | 2025-09-17 |
| 83364 | SUPPL | 2025-09-17 |
| 71574 | SUPPL | 2022-07-15 |
| 71557 | SUPPL | 2022-07-15 |
| 68263 | SUPPL | 2021-08-02 |
| 68257 | SUPPL | 2021-08-02 |
| 59975 | SUPPL | 2019-09-11 |
| 59966 | SUPPL | 2019-09-11 |
| 22863 | ORIG | 2016-05-25 |
| 19036 | SUPPL | 2015-12-02 |
| 9934 | SUPPL | 2015-12-02 |
| 32142 | ORIG | 2015-05-13 |